Home > Healthcare > Pharmaceuticals > Finished Drug Form > Pancreatic Cancer Treatment Market

Pancreatic Cancer Treatment Market Size

  • Report ID: GMI9748
  • Published Date: Jun 2024
  • Report Format: PDF

Pancreatic Cancer Treatment Market Size

Pancreatic Cancer Treatment Market was valued at USD 3 billion in 2023 and is anticipated to witness growth at a CAGR of 13.2% over the analysis period. Increasing prevalence of pancreatic cancer globally has created a pressing demand for effective treatment options.

 

For instance, as per the World Cancer Research Fund International, pancreatic cancer is the 12th most common cancer worldwide and there were more than 495,000 new cases of pancreatic cancer in 2020. Such high number of pancreatic cancer cases increases the demand for effective treatments, thereby propelling the market growth. Additionally, the expanding geriatric population, which is more susceptible to pancreatic cancer, also contributes to market growth. Moreover, significant investments in research and development by pharmaceutical companies have resulted in innovative treatments, including targeted therapy and cancer immunotherapy, further fostering a favorable environment for market expansion.

 

Pancreatic cancer treatment involves various approaches aimed at eradicating or controlling the growth of cancer cells in the pancreas. The treatment involves a multidisciplinary approach that includes chemotherapy, targeted therapy, radiotherapy, surgery, and supportive care. The specific treatment options depend on the stage of the cancer at diagnosis.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Industry size for pancreatic cancer treatment was USD 3 billion in 2023 and is projected to expand at 13.2% CAGR from 2024 to 2032, due to the increasing prevalence of pancreatic cancer across the globe.

The exocrine cancer type segment in the pancreatic cancer treatment industry accounted for USD 2.6 billion in 2023, due to the advancements in treatment options, such as surgery, chemotherapy, and targeted therapy.

The targeted therapy treatment type segment in the pancreatic cancer treatment industry accounted for 38.2% share in 2023 and is projected to grow at significant rate from 2024 to 2032, due to its precision and effectiveness in combating this challenging disease.

North America market recorded USD 1.2 billion in 2023, due to the presence of advanced healthcare infrastructure, high adoption of novel therapeutics, and a strong focus on R&D.

Pancreatic Cancer Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 322
  • Countries covered: 22
  • Pages: 185
 Download Free Sample